Improving Cancer Services ApS: Financial statements 2023
CVR: 43073575
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Improving Cancer Services ApS (CVR 43073575) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,008,925 and a net result of DKK 20,632 compared with DKK 28,677 the year before. That is an increase of 16.1% compared with the year before. Equity in the 2023 report amounted to DKK 64,649. The solvency ratio was 68.6%.
- Gross Profit
- DKK 1,008,925
- Profit/Loss
- DKK 20,632
- Equity
- DKK 64,649
- Total Assets
- DKK 94,202
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1 mio. | 21 t. | 65 t. | - |
| 2022 | - | 869 t. | 29 t. | 69 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Improving Cancer Services ApS has published its interim report for the period February 14, 2022 – December 31, 2022.
About Improving Cancer Services ApS
Improving Cancer Services ApS is a Danish company of the type Anpartsselskab based in Gudhjem, founded in 2022. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The management consists of Simon Julian Oberst. The company is owned by Simon Julian Oberst. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,279,505 and a net result of DKK 21,201 compared with DKK 22,853 the year before. Equity in the 2025 report amounted to DKK 78,702.